Atlas FDA

NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar

FDA 510(k) clearance K212289 · decided 2022-05-06

Clearance details

K-number
K212289
Device name
NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar
Applicant
Neuronetics, Inc.
Decision
Substantially Equivalent
Date received
2021-07-21
Decision date
2022-05-06
Days to decision
289 days
Clearance type
Traditional
Product code
QCI
Device class
2
Regulation number
882.5802
Medical specialty
Neurology
Advisory committee
Neurology
Location
Malvern, PA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Neuronetics

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Ultimate rTMS for OCD (M-series) (K243459)Brain Ultimate, Inc.2025-04-17
BTL-99-OC (K230657)BTL Industries, Inc.2024-02-01
CloudTMS Edge for OCD (K233742)Teleemg, LLC2023-12-22
OCD MT Cap (85-00397-000) (K231350)Neuronetics2023-06-08
CloudTMS for OCD (K221129)Teleemg, LLC2023-03-10
MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system (K193006)Tonica Elektronik A/S2020-08-09
Brainsway Deep TMS System (K183303)Brainsway , Ltd.2019-03-08
Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System (DEN170078)Brainways , Ltd.2018-08-17

Recalls involving this device

No recalls on record reference this clearance.